- Home
- PCVX vs DOO Comparison
PCVX vs DOO Comparison
Compare PCVX & DOO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$61.38
N/A
Current Price
$73.40
Company Overview
Basic Information| Metric | PCVX | DOO |
|---|---|---|
| Founded | 2013 | 1937 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 5.7B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | PCVX | DOO |
|---|---|---|
| Price | $61.38 | $73.40 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 1 |
| Target Price | ★ $98.33 | $75.00 |
| AVG Volume (30 Days) | ★ 1.5M | 128.0K |
| Earning Date | 05-27-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 0.80% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $7.28 |
| Revenue Next Year | N/A | $6.08 |
| P/E Ratio | ★ N/A | $338.95 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $28.09 | $70.51 |
| 52 Week High | $76.61 | $81.89 |
Technical Indicators
Market Signals| Indicator | PCVX | DOO |
|---|---|---|
| Relative Strength Index (RSI) | 65.05 | 38.94 |
| Support Level | $42.30 | $70.63 |
| Resistance Level | N/A | $73.79 |
| Average True Range (ATR) | 3.27 | 2.50 |
| MACD | 0.36 | -0.56 |
| Stochastic Oscillator | 72.47 | 6.78 |
Price Performance
Historical Comparison PCVX
DOO
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.